Development of a translational medicine protocol for an NCTN genitourinary clinical trial: Critical steps, common pitfalls and a basic guide to translational clinical research.

[1]  P. Hall,et al.  PD-L1 expression as a predictive biomarker in advanced non-small-cell lung cancer: updated survival data. , 2017, Immunotherapy.

[2]  K. Ballman,et al.  Biomarker: Predictive or Prognostic? , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  W. Symmans.  Translational research in the National Cancer Institute's cooperative groups. , 2014, Clinical advances in hematology & oncology : H&O.

[4]  Lawrence D. True,et al.  Guidelines for the Development and Incorporation of Biomarker Studies in Early Clinical Trials of Novel Agents , 2010, Clinical Cancer Research.